Dr. Umberto Villani earned his MSc in Bioengineering from the University of Padova, Italy, in 2018. He then worked on the biophysical modelling of magnetic resonance imaging techniques, obtaining a PhD in biomedical imaging applied to Neuroscience in 2022. Until 2024, he was a Postdoctoral Fellow in Translational Pharmacology at the National Research Council in Rome, where he contributed to the development of quantitative methods to evaluate the efficacy of novel drugs and drug combinations against tuberculosis. He is currently a Postdoctoral Researcher in Clinical Pharmacology at UCL’s School of Pharmacy, within the Clinical Pharmacology and Therapeutics Group, where his work centres on applying Modelling & Simulation techniques to accelerate the approval of new medicines for paediatric rare diseases.